EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curcuminoid supplementation alters proteomic profiles and clinical outcomes in canine primary epilepsy: A pilot study

Boonrat Chantong, Nutnicha Prakaikowit, Wanita Sangapol, Sirakarn Chatampaiwong, Sekkarin Ploypetch, Sataporn Phochantachinda, Duangthip Chatchaisak

Veterinary and Animal Science · 2026-12 · 34 · 100906

DOI: 10.1016/j.vas.2026.100906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Animal Science, 2026-12. Verfasst von Boonrat Chantong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pre-Clinic and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In dogs, primary epilepsy syndrome (PES) requires lifelong pharmacological management. Curcuminoids possess anti-inflammatory and antioxidant properties with potential neuroprotective effects. This pilot study preliminarily evaluated the clinical efficacy and molecular mechanisms of curcuminoid supplementation in canine PES.

Methods

In this prospective, open-label pilot study, eight dogs with PES on stable AED therapy received adjunctive oral curcuminoid supplementation (10-20 mg/kg/day) for 60 days. Clinical response, serum GSH/GSSG ratio (DTNB-glutathione reductase recycling assay), serum cytokine concentrations (ELISA), and global serum proteomic profiles (nano-LC-MS/MS) were assessed.

Results

Clinical response, defined as a reduction in seizure frequency (3/8) or decreased severity (1/8) was observed in 4 of 8 dogs (50%). Curcuminoid supplementation significantly increased the GSH/GSSG ratio (P = 0.046) and induced distinct proteomic changes: downregulation of mammalian target of rapamycin (mTOR) pathway components (Ras-related GTP-binding protein C and regulatory-associated protein of mTOR) and Toll-like receptor 2 (TLR2) signaling and upregulation of one-carbon metabolism (methylenetetrahydrofolate dehydrogenase) and serine/glycine/threonine metabolism (phosphoserine aminotransferase 1) enzymes.

Conclusion

Curcuminoid supplementation was safe, well tolerated, and demonstrated a clinical response rate of 50% in dogs with PES. These findings provide preliminary molecular evidence of enhanced antioxidant capacity, mTOR/TLR2 modulation, and metabolic reprogramming. As pilot observations, definitive neuroprotective conclusions require confirmation in larger controlled trials with direct neurological endpoints. Nonetheless, these data provide a molecular rationale for curcuminoids as adjunctive therapy in canine epilepsy.

Schlagwörter

Stichwörter der Autor:innen

Canine epilepsyCurcuminoidsMammalian target of rapamycin pathwayOne-carbon metabolismProteomics

Autor:innen und Institutionen

  • Department of Pre-Clinic and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
  • Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
  • Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.

Förderung

  • Mahidol University

Zitieren

APA

Chantong, B., Prakaikowit, N., Sangapol, W., Chatampaiwong, S., Ploypetch, S., Phochantachinda, S., & Chatchaisak, D. (2026). Curcuminoid supplementation alters proteomic profiles and clinical outcomes in canine primary epilepsy: A pilot study. Veterinary and Animal Science, 34, 100906. https://doi.org/10.1016/j.vas.2026.100906

Vancouver

Chantong B, Prakaikowit N, Sangapol W, Chatampaiwong S, Ploypetch S, Phochantachinda S, et al. Curcuminoid supplementation alters proteomic profiles and clinical outcomes in canine primary epilepsy: A pilot study. Veterinary and Animal Science. 2026;34:100906. doi:10.1016/j.vas.2026.100906

BibTeX
@article{Chantong2026,
  author = {Chantong, Boonrat and Prakaikowit, Nutnicha and Sangapol, Wanita and Chatampaiwong, Sirakarn and Ploypetch, Sekkarin and Phochantachinda, Sataporn and Chatchaisak, Duangthip},
  title = {Curcuminoid supplementation alters proteomic profiles and clinical outcomes in canine primary epilepsy: A pilot study},
  journal = {Veterinary and Animal Science},
  year = {2026},
  volume = {34},
  pages = {100906},
  doi = {10.1016/j.vas.2026.100906}
}
Kostenlos starten →